Quite a few insiders have dramatically grown their holdings in AbCellera Biologics Inc. ( NASDAQ:ABCL ) over the past...
Cytokinetics (CYTK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
VANCOUVER, British Columbia, May 01, 2024--AbCellera, Viking Global Investors, and ArrowMark Partners Collaborate to Launch New Biotech Companies